HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Clinical trials for HIGH-GRADE B-CELL LYMPHOMA (HGBCL) explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE B-CELL LYMPHOMA (HGBCL) trials appear
Sign up with your email to follow new studies for HIGH-GRADE B-CELL LYMPHOMA (HGBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Living Drug' trial seeks to fight tough blood cancers
Disease control Recruiting nowThis is an early-stage study to find a safe dose and check the initial safety of a new CAR-T cell therapy called GF-CART01. It is for adults aged 18-70 with certain advanced B-cell blood cancers that have come back or not responded to at least two prior treatments. The therapy in…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Phase: PHASE1 • Sponsor: GenomeFrontier Therapeutics TW Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
Last-Hope drug offered to patients with aggressive lymphoma
Disease control AVAILABLEThis program provides access to an experimental drug called odronextamab for people with advanced B-cell lymphomas that have come back or stopped responding to standard treatments. It is for patients who have run out of approved treatment options. The goal is to control the cance…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC